Long-term high-fat diet (HFD) induces both cardiac remodelling and myocardial dysfunction in murine models. The aim was to assess the time course and mechanisms of metabolic and cardiac modifications induced by short-term HFD in wild-type (WT) mice. 
Introduction
Obesity epidemic related to sedentary life and hypercaloric diet, affects all ages, genders, and socioeconomic classes. Obesity is associated with numerous pathologies including diabetes and cardiovascular diseases 1, 2 and will be a major contributor to cardiovascular mortality and morbidity in the 21st century. 3, 4 Obesity produces a variety of cardiac structural changes and haemodynamic alterations leading to a clinical syndrome known as obesity cardiomyopathy. 5 Early recognition of obesity cardiomyopathy is crucial in order to prevent patients from subsequent pathological consequences such as adverse cardiac remodelling, heart failure, arrhythmias, or death. 6 For a better understanding of obesity cardiomyopathy, several animal models have been studied, including wild type (WT) and genetically modified mice on high-fat (HFD) and/or high-sucrose diet feeding. However, it is still unclear whether an HFD is sufficient to induce myocardial dysfunction in obesity murine models with conflicting data existing in the literature.
Indeed, some studies report no adverse effect of HFD on LV structure or function by echocardiography or haemodynamic measurements after 6 weeks of HFD 7 and even longer duration 8, 9 but only a reduction of contractile reserve under a dobutamine challenge 8 while others have demonstrated a significant impairment in LVEF in the absence of changes in systemic blood pressure and fasting glucose levels within 4 weeks of the initiation of HFD. 10 Growing evidence demonstrates that deformation imaging can identify LV dysfunction earlier than conventional methods in the clinical setting of metabolic disorders. 11, 12 In murine models, our group has demonstrated that strain rate (SR) has the ability to detect subtle abnormalities despite normal LVEF and is well correlated with haemodynamic parameters of contractility such as elastance and dP/dt max . 13 We aimed (i) to study the short-term effects of HFD-induced obesity in C57/BL6 adult mice on cardiac function as assessed by systolic radial SR and in vivo haemodynamic measurements; (ii) to understand the pathological alterations that may underlie myocardial dysfunction.
Methods

Animal models
Five-month old male C57/BL6J mice (n = 18, Janvier Labs, France) were fed with chow diet (CD) (n= 10; CD, A0310, Safe Diets, France) or highfat diet (HFD) (n= 8, HFD, D12492i, Research Diets, Inc) for 20 weeks. In addition, in order to assess the short-term effects of HFD on myocardial function, 15 additional mice were sacrificed after 5 weeks of CD (n = 7) or HFD (n = 8).
The control diet, CD was composed of 13.5% of fat, 61.3% of carbohydrate, and 25.2% of protein (total energy content: 2830 kcal/kg), whilst HFD consisted of 60% of fat, 20% of carbohydrate, and 20% of protein (total energy content: 5243 kcal/kg). All mice were housed in individually ventilated cages in a dedicated animal facility at a constant temperature (22 C) and humidity (50%), with a 12-h light-dark cycle and unrestricted access to food and water. During follow-up, animals underwent a monthly metabolic and echocardiographic evaluation. Before sacrifice, all animals underwent in vivo haemodynamic measurements. All animal experiments were approved by the Institutional Animal Care and Use Committee of the French National Institute of Health and Medical Research (INSERM)-Unit 955, Créteil, France (ComEth 15-001).
Echocardiography
Mice were trained to be grasped because transthoracic echocardiography (TTE) was performed in non-sedated mice in order to avoid any cardiac depressor effect of anaesthetic agents. Typical heart rates at recording were above 600 bpm. Mice were carefully caught by the left hand and placed in supine position. Data acquisition was performed every month by a single operator (J.T.). Images were acquired from a parasternal position at the level of the papillary muscles using a 13-MHz linear-array transducer with a digital ultrasound system (Vivid 7, GE Medical System, Horton, Norway). Left ventricular (LV) diameters, anterior and posterior wall thicknesses were serially obtained from M-mode acquisition. As we expected a homogenous function and planned to compare sequential echocardiography, we used M-mode technic to assess both LV volumes, mass, and ejection fraction. Relative LV wall thickness (RWT) was defined as the sum of septal and posterior wall thickness over LV end-diastolic diameter, and LV mass was determined using the uncorrected cube assumption formula
]. Diastolic function was not assessed by echocardiography because of the heart rate above 600 bpm precluding the analysis of transmitral flow. Therefore, we assessed relaxation by dP/dt min during in vivo haemodynamic analysis. Peak systolic values of radial SR in the anterior and posterior wall were obtained using Tissue Doppler Imaging (TDI) as previously described. 13 TDI loops were acquired from the same parasternal view with a careful alignment with the radial component of the deformation 14 at a mean frame rate of 514 fps and a depth of 1 cm. The Nyquist velocity limit was set at 12 cm/s. Radial SR analysis was performed offline using the EchoPac Software (GE Medical Systems) by a single observer (G.D.) blinded to the diet of the animals. Peak systolic of radial SR was computed from a region of interest positioned in the mid-anterior wall and was measured over an axial distance of 0.6 mm. The temporal smoothing filters were turned off for all measurements. Because slight respiratory variations exist, we averaged peak systolic of radial SR on eight consecutive cardiac cycles. The intra-observer variability of radial SR was assessed (GD) using the same acquisition and same method at 24-h intervals (3.5 ± 3.4% [3.3-3.7] ).
Haemodynamic analysis
In vivo haemodynamic measurements were performed just before sacrifice (5 and 20 weeks) as previously described. 15 Haemodynamic evaluation was performed in mice placed on a homeothermic operating table under 1.5% isoflurane anaesthesia in spontaneous breathing. A 1.4-Fr microcatheter (Millar Instruments, Houston, TX, USA) calibrated manually before each experiment, was inserted via the right carotid artery into the aorta for the measurement of systolic and diastolic pressure, and then advance into the LV for measurement of end-diastolic and endsystolic pressures, peak rates of isovolumic pressure development (dP/ dt max ) and pressure decay (dP/dt min ). Data were collected after at least 10 min of steady state, using the lowest isoflurane concentration tolerated. Data were analysed using the IOX software (EMKA, France).
Metabolic tolerance tests
Metabolic tests were performed in all mice every month over a period of 20 weeks 1 day before echocardiography. Glucose tolerance test (GTT): mice were fasted for 7 h before the study, and then given glucose solution intraperitoneally (1.5 mg/g body weight). Blood samples were collected from the tail vein at baseline, 15, 30, 60, 90, 120 min after injection, and glucose concentration was measured with an automatic glucometer (Accu-Chek Performa, Roche, Germany).
Insulin tolerance test (ITT): mice were fasted for 7 h before study, and then given insulin solution intraperitoneally (0.5 mU/g of body weight, Humulin R, Lilly, France). Blood samples were collected from the tail vein at baseline, 30, 60, 90, 120 min after injection, and glucose concentration was measured.
Histology
Paraffin-embedded sections were deparaffinized using xylene and a graded series of ethanol dilutions. Heart sections were stained either with wheat germ agglutinin (plasma membrane staining, Alexa 
Apoptosis
Apoptosis was detected with terminal deoxynucleotidyl transferase UTP nick-end labelling (TUNEL) on paraffin-embedded heart sections, epitopes were retrieved by 90 C bath for 10 min. After endogenous peroxidase blockage with H 2 O 2 for 15 min, tissues were incubated in equilibration buffer and treated with terminal deoxynucleotidyl transferase (TdT) to detect TUNEL-positive (Alexa Fluor 488 conjugated) nuclei as suggested by the manufacturer (Roche, Meylan, France). Cardiomyocytes and interstitial cells were stained with a primary antibody anti-Troponin I (Abcam, UK) followed by incubation with an antirabbit secondary antibody conjugated with Alexa Fluor 555 (Invitrogen, France) for 1 h at room temperature. Fluorescence was measured using a Zeiss Imager. M2 fluorescent microscope, and quantified on digital photographs using the ImageJ software (NIH).
Malondialdehyde measurements
Myocardial lipid peroxidation was assessed by measuring malondialdehyde (MDA) levels as thiobarbituric acid reactive species (TBARS). Briefly, hearts were pulverized with mortar and pestle using liquid nitrogen and 25-30 mg of the powder was mixed with two volumes of ice cold 10% (w/v) trichloroacetate. Samples were then sonicated two times for 30 s followed by passing them through 21 G needle at least six times before centrifugation at 13 000 rpm for 5 min at þ4
C. An aliquot of the supernatant was reacted with an equal volume of 0.67% (w/v) TBA (thiobarbituricacid) at 100 C for 10 min. The samples were allowed to cool down before absorbance was read at 532 nm. The concentration of TBARS corresponding to MDA was calculated based on the extinction coefficient value of 153 000 and normalized to wet weight of the sample.
Luminex analysis
Four biomarkers were quantified in plasma samples using Luminex beadbased multiplex assay with a Bio-Plex 200 instrument (Bio-Rad) according to the manufacturer's instructions: TGFb1 using Magnetic Milliplex Map Kit (cat.# TGFMAG-64K-03, Millipore, Billerica, USA); Adiponectin and C-Reactive Protein using Magnetic Luminex screening assay kit (Cat.# LXSAMSM-1, Bio-Techne, Abington, UK); Leptin using Magnetic Luminex screening assay kit (Cat.# LXSAMSM-19, Bio-Techne, Abington, UK).
Statistical analysis
Comparison between the two groups of mice (CD and HFD) on echocardiographic, haemodynamic, metabolic, and histologic parameters of was performed using Two-way ANOVA. To assess the effect of time, comparison between echocardiographic and metabolic parameters at baseline and every month was performed using ANOVA for repeated measurements. A multivariate analysis including parameters correlated with radial SR was performed in order to identify independent factors associated with radial SR alteration. All data are reported as mean ± SEM. A probability value of <0.05 was considered statistically significant.
Results
Short-term HFD induces metabolic abnormalities and adipose tissue remodelling HFD mice displayed an increased body weight after 5 weeks and furthermore after 20 weeks of diet compared with CD mice ( Figure 1A ).
In line with the weight gain, glucose tolerance was altered as shown by the elevated area under of the curve of glucose level during intraperitoneal GTT as soon as after 5 weeks and becoming even greater after 20 weeks of HFD ( Figure 1B) .
These metabolic abnormalities were associated with substantial changes in adipose tissue structure. As shown in Figure 1C , adipocyte size was significantly larger in the HFD group when compared with CD group both after 5 and 20 weeks of HFD. Of particular note adipocyte size significantly increased in CD group with age. In parallel a significant increase in prevalence of macrophages surrounding dead adipocytes and forming crown-like structures (CLS) was observed in the HFD group both after 5 and 20 weeks ( Figure 1D ).
HFD induces an early myocardial dysfunction and a progressive LV remodelling
In HFD mice both echocardiography and in vivo haemodynamics demonstrated an early impairment of myocardial function as compared with CD mice (Table 1 and Figure 2 ). Indeed, after 5 weeks, systolic radial SR, dP/dt max , and dP/dt min were significantly lower in HFD compared with CD mice despite no significant decrease in LV ejection fraction (LVEF). At 20 weeks' follow-up a further reduction in systolic radial SR and dP/dt max and dP/dt min was observed in both groups with HFD mice displaying lower values than CD mice. Of note no significant increase in aortic blood pressure was observed with HFD ( Table 1) .
This early myocardial dysfunction was associated with a progressive LV remodelling as shown by a higher heart weight/tibia length ratio and a slight but significant increase in cardiac myocyte size in HFD mice compared with CD mice after 5 weeks of diet ( Figure 3A and B). Furthermore, HFD mice exhibited a higher LV mass starting at 10 weeks post-HFD compared with CD ( Figure 3C ) but no significant change in RWT ( Table 1) .
HFD induces myocardial fibrosis, inflammation, oxidative stress, and apoptosis
Myocardial interstitial fibrosis increased in both groups during followup but was more pronounced in the HFD group than in the CD group after both 5 and 20 weeks of HFD ( Figure 4A ). Interestingly systolic radial SR was significantly correlated with the extent of myocardial fibrosis (r = -0.56, P = 0.002, Figure 4B ). Myocardial interstitial fibrosis increase and alteration in systolic radial SR was concomitant with an important increase in leptin and TGFb1 levels with a trend to reduced adiponectin levels in the HFD group ( Figure 5 ). Macrophage number in the myocardium was similar in both groups at the early stage, but was higher in the HFD than in the CD group at 20 weeks ( Figure 6A ). HFD group also displayed an increase in TUNEL positive cells compared with CD group that was progressively more pronounced after 20 weeks of diet ( Figure 6B) . Myocardial oxidative stress, as represented by increased levels of TBARS, was evident after both 5 and 20 weeks of HFD compared with the corresponding CD groups ( Figure 6C) . CRP level progressively increased in the HFD group and was significantly higher than in CD group at 20 weeks ( Figure 5C ). Radial SR alteration was significantly associated with these anatomic, metabolic, and inflammatory parameters, but multivariate analysis identified only LV mass, leptin and myocardial macrophage infiltration as independent variables ( Table 2) .
Short-term high-fat diet compromises myocardial function
Discussion
The present study evaluated the metabolic and cardiovascular effects of HFD in WT mice during a follow-up of 20 weeks. The main findings are the early onset of cardiac dysfunction in association with the metabolic disorders and the early adipose tissue remodelling in the HFD group.
HFD murine model is a recognized model of obesity and insulin resistance. 7 As previously described, we observed an increase in glucose levels together with an impaired glucose and insulin tolerance after only 5 weeks of HFD. We did not find any effect of HFD on LV function as determined by LVEF performed serially up to 20 weeks. However, regional myocardial function assessed by systolic radial SR was altered early on in HFD-fed mice (5 weeks) and became further impaired after 20 weeks. In CD-fed mice, we also observed a slight decrease in systolic radial SR over time without any decrease in LVEF, thus confirming our previous observations of the impact of aging on myocardial function. 13 Therefore, our study clearly demonstrates the additive effect of HFD-induced metabolic disorders and physiological ageing process on myocardial function and structure. This early alteration of myocardial function in the context of HFD was confirmed by in vivo haemodynamics, which was performed at both 5 and 20 weeks of HFD. These findings demonstrate that short duration of HFD does affect myocardial function. Conflicting results exist in the literature regarding early cardiac dysfunction in metabolic alterations. [7] [8] [9] [10] Differences in experimental conditions such as the animal model, the duration of experiments, or the diet composition may explain these discrepancies. In addition, the way the myocardial function is assessed is also important. First, novel techniques exploring regional myocardial deformation such as SR imaging may display reduced contractility, before impairment of global cardiac parameters. 16 Strain rate using TDI has been indeed validated as a robust method for quantifying LV regional systolic function in small animals under different pathologic conditions, confirming its superiority over Speckle Tracking Imaging. 14, 17, 18 Our data demonstrate early alterations of cardiac function by both radial SR and haemodynamic parameters (dP/dt max ). Such abnormalities were reported by using a cardiac magnetic resonance protocol called Displacement Encoding with Stimulated Echoes (DENSE). 16 However, reductions in strain were limited in the subepicardium but preserved in the subendocardium with no change observed in radial deformation, the major component of myocardial function in mice. 19 Secondly, anaesthesia may have a non-trivial cardiodepressive effect on both heart rate and myocardial functional indices. 19 To overcome this caveat, in the present study we performed a comprehensive echocardiographic follow-up cardiac function by both global and regional deformation indices in conscious mice, unstressed because trained to be manipulated, without the risk that anaesthesia may induce severe alteration in ejection fraction 10 and/or mask subtle differences between chow and HFD-fed groups. Thirdly, we were able to evaluate both the aging and metabolic impact on myocardial function and structure because we performed this study in 5-month-old mice. Indeed, the absence of difference in LV function between HFD and CD groups in previous studies may also be explained by aging which induces per se a progressive LV dysfunction converging the dietary effects to a single dysfunction. Furthermore, we explored the potential mechanisms that might contribute to the early alteration of myocardial function in HFD mice. Indeed identifying a precise and single mechanism underlying the effect of obesity on the heart is challenging.
First, we explored the role of adipose tissue, which is an endocrine organ that plays a major role in the pathogenesis and complications of obesity. Body weight follow-up, GTT and ITT confirmed that the HFD mice developed impairment of glucose homeostasis compared with CD mice. 7 After 5 weeks of HFD, we showed an important remodelling of visceral adipose tissue with large adipocytes surrounded by inflammatory cells emerging as CLS. At the end of the follow-up, adipose tissue remodelling also occurred in the CD group induced by aging but was less pronounced in magnitude than in the HFD group. These histological modifications were associated with an increase in plasma leptin levels which detrimental effects on the cardiovascular system have been reported in the context of obesity and include LV hypertrophy, myocardial fibrosis, and apoptosis. 20 Adiponectin on the other hand is a cardioprotective hormone that is known to limit LV hypertrophy, oxidative stress, and inflammation. Decrease in myocardial contractility was concomitant with a slight but significant increase in cardiomyocyte size, LV mass, interstitial myocardial fibrosis, and apoptosis. In parallel with the time spent on HFD, interstitial myocardial fibrosis further increased and was accompanied by systolic and diastolic dysfunction with a decrease of both dP/dt max and dP/dt min . This is consistent with previous preclinical studies reporting the effect of HFD on myocardial hypertrophy and fibrosis and the role of GSK-3 inhibition to mediate these effects. 21 Despite the absence of independent association between SR and myocardial fibrosis on multivariate analysis, our observation highlights the early and subtle contribution of hypertrophy and fibrosis to myocardial dysfunction in metabolic disorders. Our data show that the profibrotic effect is associated with an early increase in TGF-b1 which induces the extracellular matrix remodelling by angiotensin II and aldosterone stimulation. 22 These observations provide the rationale for aldosterone antagonism to reduce myocardial fibrosis in the context of metabolic disorders. However, after 20 weeks of HFD, radial SR in HFD mice remained consistently below that of CD mice, which was most remarkable when the reduction in radial SR occurred at equivalent interstitial myocardial fibrosis. This raises the possibility that fibrosis was only one explanation for reduced systolic SR, where further, unaccounted contributors may also take their share. Indeed, multivariate analysis identified that LV mass, leptin, and macrophages infiltration were independently associated with radial SR hinting at further components to HFD's 'toxicity' on myocardial function. The fact that fibrosis was not independently associated with SR is probably related to a degree of co-linearity between the two variables.
Clinical implications
Cardiovascular diseases are the main cause of morbidity and mortality in obese patients. Cardiac alterations related to obesity include progressive LV remodelling with hypertrophy and late dilatation, and systolic dysfunction that may lead to heart failure. In human studies it is possible to assess these parameters at one time point and to follow changes in time, but it is difficult to evaluate the impact of obesity on myocardial function from early to late stage. Animal models offer the ability to do such follow-up in a well-monitored evolution of the disease. Translating the findings in HFD murine models to humans affected by obesity should lead to a careful monitoring of both myocardial function and structure to assess the impact of chronic metabolic disorders on the heart. Indeed recent clinical studies demonstrate that strain is able to unmask subtle systolic abnormalities in patients with metabolic disorders speculating that such an abnormality could be considered an early marker of metabolic cardiomyopathy. 23, 24 Our experimental data support such a statement and also demonstrate the progressive deterioration of systolic function in a time-dependent fashion together with poor glucose control. Furthermore, our findings highlight the importance of such abnormalities with impact on LV remodelling as recently suggested in a clinical study reporting after 2-year follow-up, a progression of subclinical dysfunction together with an increase in LV mass but no change in LVEF. 25 However, we acknowledge that we need to be cautious in translating these findings to humans because 60% fat in daily diet exceeds even the fat content of the classical Western diet.
Conclusion
To our knowledge, this is the first longitudinal study involving SR imaging in diet-induced obese mice demonstrating unequivocal early alteration of cardiac function. The sequence of events elicited in the development of the cardiometabolic disease in mice is of potential interest to build diagnostic and therapeutic strategies in humans.
